Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Stock data | 2023 | Change |
---|---|---|
Price | $111.32 | N/A |
Market Cap | $29.05B | N/A |
Shares Outstanding | 261.00M | -6.45% |
Employees | 47.04K | N/A |
Shareholder Equity | -2.85B | 303.82% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 111.32 | N/A |
P/S Ratio | 0.14 | N/A |
P/B Ratio | -10.19 | N/A |
P/FCF | 12.32 | N/A |
POE | 0.00 | N/A |
Dividends | 2023 | Change |
---|---|---|
Dividend Yield | 1.81% | N/A |
Dividend per share | 2.0115 | N/A |
Dividend Payout Ratio | 2.0038 | N/A |
Growth | 2023 | Change |
---|---|---|
ROIC | 0.0626 | N/A |
WACC | 0.0044 | N/A |
CAPEX | -469.00M | N/A |
Return on Equity | -0.0919 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $205.01B | N/A |
Earnings | $262.00M | N/A |
Free Cash Flow | $2.36B | N/A |
EPS | 1.00 | N/A |
Earnings Yield | 0.009 | N/A |
Gross Margin | 0.0336 | N/A |
Operating Margin | 0.0086 | N/A |
Net income margin | 0.0013 | N/A |
FCF Margin | 0.0115 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $43.42B | N/A |
Total Debt | $4.70B | N/A |
Cash on Hand | $4.04B | N/A |
Debt to Equity | -16.2287 | -74.30% |
Cash to Debt | 0.8600 | -3.09% |
POE | 0.0000 | N/A |
Current Ratio | $1.00 | -6.89% |
Other data | 2023 | Change |
---|---|---|
Buyback Yield | 0.0688 | N/A |